background
common
acut
infect
occur
respiratori
tract
recent
discoveri
sever
novel
virus
markedli
increas
repertoir
agent
understood
caus
present
acut
respiratori
diseas
object
understand
need
rel
import
newli
discov
pathogen
clinic
set
provid
clinician
indic
appropri
diagnost
therapeut
target
address
quantif
diseas
burden
respiratori
virus
hospit
patient
undertaken
studi
design
diseas
burden
caus
respiratori
virus
hospit
patient
quantifi
use
world
health
organ
endors
dali
model
diagnost
test
result
sampl
collect
three
year
adenoviru
adv
influenza
b
parainfluenza
virus
respiratori
syncyti
viru
hrsv
previous
publish
retrospect
screen
human
metapneumoviru
rhinovirus
four
respiratori
coronavirus
appli
dali
model
disabl
weight
calcul
per
hospit
patient
age
band
group
result
strikingli
differ
diseas
burden
profil
observ
children
adult
adenovirus
among
lead
caus
respiratori
present
children
adult
hrsv
influenza
consist
one
greatest
caus
diseas
regardless
sampl
popul
rhinovirus
signific
pathogen
group
except
age
year
immunocompromis
patient
rhinovirus
lead
viral
caus
diseas
conclus
analys
provid
framework
use
identifi
finit
resourc
direct
respiratori
therapeut
vaccin
develop
infect
respiratori
tract
common
type
acut
infect
global
adult
children
europ
lower
respiratori
tract
infect
lrti
eighth
lead
caus
diseas
recent
year
discoveri
sever
novel
virus
associ
high
morbid
respiratori
outcom
includ
human
metapneumoviru
hmpv
human
coronavirus
hcov
human
rhinoviru
speci
c
hrvc
markedli
increas
repertoir
agent
associ
acut
respiratori
tract
infect
arti
present
signific
challeng
microbiolog
diagnost
attempt
prevent
respiratori
viru
infect
usual
limit
vulner
high
risk
group
immunocompromis
elderli
includ
measur
vaccin
cohort
reduc
exposur
risk
prophylaxi
vaccin
protect
infect
princip
agent
respiratori
diseas
wide
avail
influenza
b
respiratori
season
hrsv
sever
epidem
hrsv
posit
patient
may
cohort
attempt
reduc
transmiss
viru
patient
near
patient
test
npt
hrsv
infect
recommend
infant
requir
hospit
admiss
acut
bronchiol
facilit
time
cohort
one
studi
previous
attempt
quantifi
diseas
burden
attribut
respiratori
virus
respiratori
tract
infect
commun
base
adult
age
prospect
diagnos
diseas
burden
associ
panel
respiratori
virus
quantifi
use
method
us
institut
medicin
prioritis
new
vaccin
develop
strategi
diseas
import
unit
state
import
clinic
outcom
infect
recent
discov
lower
preval
virus
systemat
quantifi
disabl
adjust
life
year
dali
model
endors
world
health
organ
methodolog
priorit
intervent
health
sector
base
potenti
reduc
burden
diseas
dali
combin
time
lost
due
morbid
mortal
attribut
singl
numer
valu
measur
associ
burden
caus
diseas
outcom
model
employ
quantifi
diseas
burden
commonli
detect
patient
age
stratifi
hospit
patient
cohort
provid
indic
resourc
might
effect
use
diagnost
patient
manag
treatment
sampl
juli
june
result
routin
diagnost
screen
test
sampl
collect
hospit
patient
avail
adenoviru
adv
influenza
season
influenza
b
parainfluenza
virus
hrsv
addit
viru
test
result
avail
subset
sampl
hmpv
human
rhinovirus
speci
b
c
togeth
sampl
coronavirus
previou
studi
purpos
studi
addit
screen
rhinovirus
undertaken
sampl
collect
septemb
februari
use
previous
describ
pcr
protocol
panrhinoviru
detect
ethic
approv
work
grant
lothian
region
ethic
committe
sampl
respiratori
archiv
subject
anonymis
institut
review
board
specif
waiv
need
patient
consent
retain
patient
inform
includ
age
sex
place
sampl
collect
eg
accid
emerg
specifi
hospit
ward
clinic
inform
record
referr
form
sampl
test
posit
one
virus
includ
studi
consid
separ
mix
infect
exclud
subsequ
analys
due
differ
sampl
strategi
differ
patient
popul
appropri
undertak
analys
agestratifi
way
consid
immunocompromis
patient
separ
clinic
data
dali
model
quantifi
morbid
associ
differ
clinic
outcom
assign
disabl
weight
scale
wherebi
morbid
death
clinic
data
relat
sampl
could
assign
one
categori
categori
treat
hierarch
fashion
preced
given
order
urti
lrti
identifi
outcom
causal
associ
infect
present
could
assum
categori
analys
use
dali
model
clinic
data
indic
lrtiurti
associ
sampl
exclud
diseas
burden
calcul
includ
sampl
clinic
data
avail
sampl
collect
chronic
patient
exclud
includ
small
proport
sampl
current
understand
diseas
exacerb
preclud
estim
proport
patient
would
respiratori
present
sever
would
significantli
infect
viru
might
contribut
literatur
review
identifi
death
infect
caus
asthma
signific
outcom
respiratori
viru
infect
refer
supplementari
materi
rate
outcom
due
infect
respiratori
viru
estim
literatur
tabl
supplementari
materi
incorpor
model
consequ
hierarch
categor
clinic
data
immunocompromis
patient
inform
respiratori
present
avail
two
approach
estim
rate
urti
lrti
immunocompromis
patient
first
literatur
second
use
rate
observ
otherwis
healthi
hospit
individu
edinburgh
latter
approach
chosen
edinburgh
archiv
may
reflect
sampl
popul
term
criteria
sampl
test
virus
present
clinic
definit
rate
death
lrti
urti
due
respiratori
viru
infect
estim
immunocompromis
patient
respiratori
viru
infect
identifi
due
pauciti
publish
studi
patient
group
disabl
weight
global
burden
diseas
studi
gold
standard
studi
quantifi
diseas
burden
use
dali
weight
assign
lrti
studi
popul
lrti
assum
caus
hospit
higher
disabl
weight
deem
appropri
rang
disabl
weight
consid
reflect
possibl
implic
hospit
due
lrti
fell
weight
consid
appropri
individu
admit
intens
therapi
unit
itu
disabl
weight
attribut
lrti
assign
virusdepend
basi
rang
proport
rate
itu
admiss
diagnosi
lrti
exampl
patient
lrti
test
singli
posit
adv
admit
itu
disabl
weight
sf
assign
urti
assum
caus
hospit
assum
caus
infect
respiratori
viru
global
burden
diseas
studi
disabl
weight
deem
inappropri
clinician
felt
present
warrant
document
valu
pharyng
appli
disabl
weight
lrti
calcul
otherwis
healthi
patient
appli
immunocompromis
popul
itu
admiss
immunocompromis
patient
could
assum
due
respiratori
infect
method
prefer
distinct
disabl
weight
calcul
group
infect
caus
asthma
global
burden
diseas
studi
disabl
weight
appli
model
paramet
durat
disabl
associ
urti
lrti
estim
literatur
viru
specif
basi
tabl
supplementari
materi
use
assumpt
describ
murray
applic
social
life
expect
paramet
immunocompromis
individu
otherwis
healthi
individu
consid
ethic
viabl
approach
purpos
studi
dr
claudia
stein
per
comm
dali
model
regard
life
expect
maximum
achiev
length
life
sex
specif
mean
life
expect
scotland
describ
offic
nation
statist
use
dali
calcul
age
stratifi
manner
immunocompromis
patient
consid
separ
calcul
diseas
burden
estim
burden
diseas
associ
respiratori
viru
calcul
use
dali
formula
disabl
weight
c
paramet
age
weight
function
paramet
age
weight
function
use
world
bank
studi
age
diseas
onset
midrang
valu
age
band
appli
l
durat
disabl
case
fatal
time
age
onset
life
expect
r
social
discount
rate
social
discount
rate
use
global
burden
diseas
studi
appli
absolut
dali
measur
standard
common
metric
dali
per
popul
divid
total
number
dali
calcul
proport
sampl
clinic
data
avail
viru
studi
procedur
enabl
fair
comparison
virus
number
sampl
taken
number
sampl
clinic
data
avail
vari
studi
popul
hospit
individu
reflect
popul
scotland
quantif
commun
base
diseas
burden
associ
respiratori
virus
outsid
scope
studi
quantif
diseas
burden
associ
respiratori
viru
requir
calcul
sampl
frequenc
breakdown
clinic
data
determin
itu
admiss
rate
number
sampl
test
frequenc
sampl
test
singli
posit
viru
summar
tabl
rhinovirus
hrsv
influenza
sampl
test
viru
detect
frequenc
rang
rhinovirus
rate
admiss
itu
tabl
associ
viru
given
fell
rang
rhinovirus
adv
rate
respiratori
viru
infect
associ
lrti
urti
respiratori
outcom
immunocompromis
patient
indic
fig
hrsv
frequent
associ
lrti
respiratori
virus
wherea
frequent
associ
upper
respiratori
present
comparison
virus
proport
viru
posit
sampl
collect
immunocompromis
patient
highest
rhinovirus
lowest
hrsv
burden
diseas
commonli
detect
respiratori
virus
describ
tabl
children
year
age
hrsv
clearli
lead
caus
diseas
attribut
nearli
dali
per
hospit
popul
adenovirus
rhinovirus
also
signific
pathogen
age
group
parainfluenza
virus
caus
less
diseas
associ
least
diseas
virus
analys
older
children
year
old
hrsv
lead
caus
diseas
differ
sampl
strategi
age
categori
complic
direct
comparison
differ
age
group
much
lower
score
age
group
compar
younger
children
impli
less
diseas
older
children
rhinovirus
adenovirus
score
highli
compar
virus
age
group
parainfluenza
virus
maintain
minim
role
diseas
adult
year
age
influenza
lead
caus
diseas
although
score
dali
per
popul
low
comparison
lead
caus
diseas
age
group
age
group
hmpv
hrv
associ
respiratori
diseas
hospit
popul
influenza
retain
statu
lead
viral
caus
diseas
older
adult
much
higher
dali
score
influenza
b
hrsv
also
score
highli
fulli
acknowledg
difficulti
compar
diseas
burden
age
group
see
interest
score
hrsv
age
group
higher
observ
immunocompromis
subject
hrsv
rhinovirus
score
similarli
top
tabl
adenovirus
influenza
hmpv
compar
dali
score
immunocompromis
patient
adenovirus
frequent
associ
diseas
outcom
outsid
respiratori
umbrella
caution
requir
interpret
find
coronavirus
caus
least
diseas
immunocompromis
patient
age
group
burden
diseas
caus
differ
respiratori
virus
remark
variabl
fig
strike
increas
import
influenza
virus
b
age
occur
invers
decreas
diseas
burden
adenovirus
parainfluenzaand
coronavirus
maxim
impact
intermedi
age
bracket
encompass
year
old
larg
attribut
lack
diseas
caus
virus
patient
group
hrsv
substanti
caus
diseas
regardless
age
hmpv
hrv
caus
diseas
adult
ratio
diseas
burden
attribut
viru
infect
compar
respiratori
diseas
nonvir
unidentifi
caus
diminish
increas
age
tabl
like
reflect
increas
incid
bacteri
infect
older
age
group
secondari
contributor
may
reduc
diseas
burden
respiratori
viru
infect
increas
age
diseas
burden
profil
compar
male
femal
fig
greater
score
diseas
burden
usual
observ
male
femal
viru
proport
diseas
attribut
viru
differ
male
femal
hospit
popul
hrsv
lead
caus
diseas
across
children
immunocompromis
patient
signific
caus
diseas
adult
close
relat
hmpv
caus
diseas
hospit
age
cohort
although
less
hrsv
consist
previou
report
associ
sever
diseas
mortal
older
individu
rhinovirus
signific
caus
respiratori
ill
particularli
young
children
fig
three
known
speci
rhinovirus
hrva
hrvb
hrvc
compris
well
hundr
type
around
quarter
third
rhinoviru
detect
edinburgh
studi
popul
speci
c
increas
evid
suggest
hrvc
type
similar
clinic
relev
rhinovirus
assign
speci
find
rhinovirus
lead
caus
acut
viral
respiratori
ill
immunocompromis
patient
present
import
opportunist
pathogen
data
togeth
highlight
import
includ
rhinovirus
diagnost
screen
protocol
influenza
lead
viral
caus
diseas
hospit
patient
age
year
increas
morbid
influenza
resembl
infect
outcom
human
virus
measl
varicella
zoster
viru
epstein
barr
viru
show
greater
diseas
sever
adult
compar
children
differ
proport
diseas
burden
attribut
commonli
detect
virus
found
male
femal
fig
infant
male
rel
smaller
airway
size
compar
femal
age
increas
likelihood
blockag
exacerb
respiratori
diseas
age
stratifi
serolog
studi
demonstr
seroconvers
rate
approach
ubiquit
respiratori
virus
studi
fig
rel
diseas
burden
caus
commonli
detect
respiratori
virus
male
compar
femal
adv
adenoviru
flu
influenza
piv
parainfluenza
viru
hrsv
human
respiratori
syncyti
viru
hcov
human
coronavirus
hrv
human
rhinoviru
physiolog
differ
lung
male
femal
still
appar
greater
diseas
sever
observ
young
male
compar
femal
peer
hrsv
infect
may
therefor
wide
applic
respiratori
viru
infect
differ
commun
base
hospit
base
caus
diseas
burden
appar
comparison
data
nicholson
studi
determin
follow
viru
rank
descend
order
import
commun
base
adult
year
age
rhinovirus
studi
predat
discoveri
rhinoviru
speci
c
caus
unknown
aetiolog
coronavirus
studi
prior
discoveri
influenza
virus
b
hrsv
studi
quantifi
diseas
burden
hmpv
fifth
sixth
greatest
caus
diseas
adult
year
age
ahead
coronavirus
studi
predat
discoveri
hmpv
two
four
coronavirus
rhinoviru
speci
c
nicholson
found
rhinovirus
associ
greater
diseas
burden
coronavirus
commun
keep
observ
hospit
popul
influenza
b
far
signific
hospit
commun
base
adult
dali
model
dynam
chang
preval
suscept
popul
clinic
present
captur
incorpor
model
determin
worst
caus
diseas
real
time
though
investig
like
dali
score
fluctuat
season
year
year
valu
method
allow
rapid
determin
clinic
signific
recent
discov
newli
emerg
virus
evid
develop
largethroughput
screen
techniqu
improv
clinic
data
manag
increas
potenti
futur
studi
kind
identifi
greatest
caus
diseas
inform
diagnost
therapeut
decis
make
studi
provid
framework
prospect
analys
captur
clinic
data
patient
follow
determin
diseas
durat
case
fatal
rate
viral
bacteri
respiratori
pathogen
data
avail
dali
score
appli
directli
clinic
decis
make
hope
direct
clinic
manag
drive
futur
author
declar
conflict
interest
design
execut
report
studi
ethic
approv
work
grant
lothian
region
ethic
committe
sampl
respiratori
archiv
subject
anonymis
institut
review
board
specif
waiv
need
patient
consent
